On the pharmacology and biochemistry of the amine‐uptake mechanism in human blood platelets

Authors:

Abstract
1 The uptake of 5-hydroxytryptamine (5-HT) by human blood platelets in vitro has been studied with the object of identifying the biochemical mechanisms involved. 2 Drugs active in adrenergic systems are only moderate inhibitors of uptake, although prenylamine is as active as the less potent tricyclic anti-depressive drugs; phenoxybenzamine is almost inactive as a competitive inhibitor but is effective if pre-incubated with the platelets beforehand. This parallels its pharmacological pattern of action. 3 Inhibitors of oxidative phosphorylation do not inhibit 5-HT uptake, but iodoacetate inhibits, if pre-incubated with the platelets; p-chloromercuribenzoate does also, when the platelets are suspended in synthetic medium, but not in plasma. 4 Ouabain causes significant inhibition at 10−7m; by 10−6m it achieves its maximal effect, namely 40% inhibition; in K+-deficient medium, uptake falls to 30% of normal; the K+-dependent fraction of the uptake includes the ouabain-sensitive component. Mg++ has no effect. 5 A drug not possessing the imipramine structure, which has been tried in the treatment of depressive illness, 4-phenyl bicyclo (2,2,2) octan-1-amine, is a highly potent inhibitor of 5-HT uptake.

This publication has 23 references indexed in Scilit: